Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2021	Mar. 31, 2021
Current assets:
Cash and cash equivalents	$ 40,467	$ 9,500
Restricted cash	500	0
Accounts receivable, net, including related parties	2,489	1,618
Inventory	5,956	2,223
Prepaid expenses and other current assets	1,249	953
Total current assets	50,661	14,294
Property and equipment, net	1,897	1,360
Goodwill	1,250	1,302
Intangible assets, net	691	914
Investment in joint venture	61	0
Other assets	282	274
Total assets	54,842	18,144
Current liabilities:
Accounts payable and accrued expenses	4,749	3,140
Deferred revenue	267	505
Development loan	0	10,000
Revolving credit facility, including accrued interest	368	10,150
Unfunded commitment to joint venture	0	1,866
Accrued payroll and benefits	1,239	1,410
Total current liabilities	6,623	27,071
Revolving credit facility	12,000	0
Promissory note	0	16,128
Total liabilities	18,623	43,199
Commitments and contingencies (Note 8)
Common stock, shares authorized (in shares)	750,000,000	750,000,000
Stockholders’ equity (deficit):
Common stock, $0.0001 par value; 750,000,000 shares authorized as of December 31, 2021 and March 31, 2021, and 53,066,922 and 40,531,996 shares issued and outstanding as of December 31, 2021 and March 31, 2021, respectively	$ 5	$ 4
Additional paid-in capital	210,841	144,201
Accumulated deficit	(173,639)	(168,403)
Accumulated other comprehensive loss	(988)	(857)
Total stockholders’ equity (deficit)	36,219	(25,055)
Total liabilities and stockholders’ equity (deficit)	$ 54,842	$ 18,144